Prabhdeep Singh - 08 Jul 2021 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
Chief Growth Officer
Signature
/s/ Gia Lee, as Attorney-in-Fact
Issuer symbol
CLOV
Transactions as of
08 Jul 2021
Net transactions value
$0
Form type
4
Filing time
12 Jul 2021, 19:09:28 UTC
Previous filing
12 Jul 2021
Next filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +211,193 $0.000000 211,193 08 Jul 2021 Direct F1
transaction CLOV Class A Common Stock Award $0 +52,798 +25% $0.000000 263,991 08 Jul 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in equal annual installments over four years, beginning on July 6, 2022, subject to the continuous service of the Reporting Person on each vesting date.
F2 Represents shares of Class A common stock underlying RSUs. The RSUs will vest in full on July 6, 2022, subject to the continuous service of the Reporting Person on such vesting date.